Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Animal healthcare focuses on effective animal health management by diagnosing and treating the diseases. Outbreak of animal diseases restrict trading of animal origin products and increases cost of disease management and also hampers the global economy.
The Europe animal healthcare market size is estimated to be valued at US$ 13,119.7 million in 2020 and is expected to exhibit a CAGR of 4.5% over the forecast period (2020-2027).
Figure 1. Europe Animal Healthcare Market Value (US$ Mn), by Country, 2020
Increasing incidence of zoonotic viral pathogens and increasing expansion strategies adopted by manufacturers are factors propelling growth of the Europe animal healthcare market
Increasing product launches and strategic collaborations between manufacturers and regional authorities to address increasing demand for animal healthcare is contributing to the market growth. According to the Animal Disease Notification System (ADNS), 2018, in Bulgaria, around 14 outbreak of A(H5N8) viruses and highly pathogenic avian influenza (HPAI) in poultry was reported from August 2018 to November 2018. To address the increasing prevalence of these zoonotic diseases, regional governments are focused on improving animal health by collaborating with manufacturers to promote research & development of new drug treatments.
Moreover, strategies adopted by manufacturers to expand their product portfolio and market presence is expected to propel growth of the market over the forecast period. For instance, in July 2019, Ceva Santé Animale acquired IDT Biologika GmbH’s veterinary biopharmaceutical portfolio, which is expected to strengthen Ceva’s product offerings.
Europe Animal Healthcare Market Report Coverage
||Market Size in 2020:
||US$ 13,119.7 Mn
|Historical Data for:
||2016 to 2019
||2020 to 2027
|Forecast Period 2020 to 2027 CAGR:
||2027 Value Projection:
||US$ 17,837.8 Mn
- Europe: Germany, U.K., Spain, France, Italy, Russia, Switzerland, Netherlands, and Rest of Europe
- By Animal Type:
- Livestock: Bovine, Porcine, Poultry, Other.
- Companion: Canine, Feline, Equine.
- By Route of Administration: Oral, Topical.
- Injectable: Subcutaneous Injections, Intramuscular Injections, Intravenous Injections, Intra-peritoneal Injections, Others.
- By Indication: Infectious Diseases, Pain, Auto-immune Disease, Others.
Merck & Co., Inc., Virbac, Dechra Pharmaceuticals Plc., Vetoquinol S.A., Zoetis Inc., Ceva Santé Animale, Bayer AG, Elanco, Evonik Industries AG, and Archer Daniels Midland Company
- Increasing incidence of zoonotic viral pathogens
- Increasing demand for protein from animal source
- Increasing government initiatives to provide improved animal healthcare
|Restraints & Challenges:
- Stringent regulations for sales and usage of antibiotics
- High cost of animal healthcare services
Moreover, increasing implementation of regulatory guidelines by regional and local authorities in Europe for overall improvement of animal healthcare is expected to drive the market growth over the forecast period. For instance, in 2018, the European Medicine Agency initiated multi-stakeholder workshop for providing guidelines on veterinary regulatory science and offered proposals for development of veterinary medicine.
Figure 2. Europe Animal Healthcare Market Share (%), by Indication, 2020
Increasing in the animal farming is expected to drive the market growth over the forecast period
The significant increase in animal farming in Europe has led to a rise in demand for efficient animal health services in order to improve food safety. According to the U.S. Department of Agricultural (USDA) report published in 2018, Lithuania is the largest poultry meat producer among the Baltic States in Europe, and production of chicken meat in Lithuania was around 110,700 MT in 2015, which was an increase of 11% from 2014.
Increasing number of regulations for animal vaccinations have led to high adoption of animal health products, which is expected to drive the market growth over the forecast period. For instance, the European Commission for the control of foot-and-mouth disease (EuFMD), and the Food and Agriculture Organization developed a progressive control pathway for managing foot-and-mouth disease (FMD).
Europe Animal Healthcare Market Restraints
However, stringent regulations on sales and usage of antibiotics, and high cost of animal healthcare services are expected to hamper growth of the Europe animal healthcare market. For instance, in 2017, the HealthforAnimals Association launched Antibiotics Commitment, a program associated with antimicrobial resistance (AMR), which promotes responsible use of antibiotics. Such awareness programs and stringent regulations have led to a decline in sales of antimicrobial agents used for veterinary treatment. According to the European Medicines Agency (EMA) report published in October 2018, there was 20% decrease in the overall sales of veterinary antimicrobials across Europe between 2011 and 2016.
Europe Animal Healthcare Market – Impact of Coronavirus (Covid-19) Pandemic
COVID-19 has had a significant impact on the livestock sector. The actions taken in many countries across the world to stop the spread of the coronavirus such as travel restrictions, nationwide lockdowns, and border controls have led to the following consequences:
- Difficulty in transporting live animals and animal products such as milk, meat, and eggs
- Restrictions and limitations on seasonal border crossings with ruminants
- Restricted capacity to purchase necessary production inputs
- Restricted access to labor and professional services
Such factors have led to a decrease in sales and processing capacity of animal products, and a slowdown of the market growth.
Major players operating in the Europe animal healthcare market include Merck & Co., Inc., Virbac, Dechra Pharmaceuticals Plc., Vetoquinol S.A., Zoetis Inc., Ceva Santé Animale, Bayer AG, Elanco, Evonik Industries AG, and Archer Daniels Midland Company.